Business Regrow Biosciences gets USFDA Nod for Phase II trials of ‘OSSGROW’ for Osteonecrosis in the US News Streamline Posted on 4 years ago OSSGROW is India’s first FDA (DCGI) approved product that has treated over 1000 patients across 200 hospitals... Read More Read more about Regrow Biosciences gets USFDA Nod for Phase II trials of ‘OSSGROW’ for Osteonecrosis in the US
